Apoptotic 20dead 20cells
Logo 20small

Apop Imaging

Apop Imaging will launch its patented CalRexin globally (> $450 mio/year market), to provide researchers with powerful new tools to image in vivo cell events.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location North Melbourne, Victoria, Australia
  • Currency AUD
  • Founded October 2016
  • Employees 2
  • Incorporation Type C-corp
  • Website apopimaging.com.au

Company Summary

Apop Imaging Pty Ltd is a Melbourne based biotech start up company founded to bring novel imaging tools to a global biomedical research market. Apop Imaging was registered in October 2016 and completed a seed funding round led by Geelong and Melbourne Angels in 2018. The high calibre board and management team has secured key partnerships for R&D, and the company is on track to commercialise its first product at the end of 2019.


  • Inventor of the concept and patent initiator, Peter's deep experience has led to the product 'Calrexin'.

  • Phil has 25 years leading in the pharma and biotech industries, running everything from start-ups to Billion Euro global pharmaceutical franchises. Phil has a BSc. a grad Dip Psych, is a GAICD and has had executive education on 3 continents. Phil has deep experience in commercialisation of complex products in highly scientific markets, and brings a strong fiscal discipline paired with a keen understanding of behavioural marketing and leadership